Correlation Between Mink Therapeutics and Genenta Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Genenta Science SpA, you can compare the effects of market volatilities on Mink Therapeutics and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Genenta Science.

Diversification Opportunities for Mink Therapeutics and Genenta Science

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mink and Genenta is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Genenta Science go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Genenta Science

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Genenta Science. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.29 times less risky than Genenta Science. The stock trades about -0.02 of its potential returns per unit of risk. The Genenta Science SpA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  501.00  in Genenta Science SpA on September 1, 2024 and sell it today you would earn a total of  19.00  from holding Genenta Science SpA or generate 3.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy97.03%
ValuesDaily Returns

Mink Therapeutics  vs.  Genenta Science SpA

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Genenta Science SpA 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Genenta Science SpA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Genenta Science sustained solid returns over the last few months and may actually be approaching a breakup point.

Mink Therapeutics and Genenta Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Genenta Science

The main advantage of trading using opposite Mink Therapeutics and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.
The idea behind Mink Therapeutics and Genenta Science SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets